Thursday, March 22, 2012

Research ethics as a sideshow

There seems to be a new approach to the publication of research studies that have been conducted in a questionable way from an ethical point of view, or are otherwise regarded as 'ethically hot.' Call it the pre-emptive strike approach: you still publish the paper, but you also simultaneously publish editorials that criticize the researcher's ethics. A way of having your cake and eating it too. The researchers and their scientific readership are happy, because they get to look at the data; the ethics people are happy-ish, because at least the problems with the study have been raised. I am reminded of the male circumcision and HIV studies in 2007, where an article was first rejected by the Lancet, and then subsequently published in PLoS Medicine with accompanying ethical commentary.

This time around, it is a tuberculosis treatment study. In the most current issue of the International Journal of Tuberculosis and Lung Disease, Aung et. al. describe how their operational research compared two treatment regimes, in order to evaluate the value of extending the intensive phase of anti-TB treatment for one month. The researchers did not ask participants for informed consent, arguing that: (1) neither of the treatment arms were likely to cause harm (2) the participants were be unlikely to be capable of making a rational choice to decide to participate (3) asking them to participate might lead to selection bias. The study was approved by the Bangladesh Medical Council Ethics Review Committee, and published by the International Journal of Tuberculosis and Lung Disease in full knowledge that informed consent was not sought. And published along with two (not one, but two) editorials that reject all three of the justifications given for not obtaining consent from participants.

So it goes. Another possibility would have been not to publish the article; a possible option now is to retract it. But I doubt this will happen. It seems that if an article looks sufficiently important, as long as the research was approved by an ethics committee (even if they admittedly dropped the ball), then it is acceptable to publish, as long as there is an accompanying ethics sideshow.

Labels: , , ,

Saturday, February 25, 2012

Research ethics committees in developing countries: something old, something new

February has been a rough month for bioethics in the USA. Alleged conflicts of interest at the American Journal of Bioethics -- the top ranked bioethics journal -- has lead to a kind of feeding frenzy of accusation, distain and soul-searching in regard to the whole idea of bioethics and how it is practiced in it's most powerful home. Is bioethics a lousy kind of philosophy? Does it just consist in rationalizing the newest biotechnology that comes along, and running intellectual roughshod over whatever traditional values (often religious) might be threatened by that technology? Is that why bioethicists are lured to agencies and institutions that are part of one might call the military-industrial-university-biotech-pharma complex? Is bioethics losing ability to speak truth to power, because they are part of (or eating hors d'oeuvres with) the 1%?

Perhaps on another occasion there will be room for reflection about whether all this should be a cautionary tale for bioethics in other countries in the world, how much of it is true, and how much of it is overblown to serve the interests of other agendas. For my part, I have been lying low, staying away from bioethics news, and looking at what other journals have been putting out. A recent research ethics article in the Journal of Medical Ethics caught my eye, called 'Ethical Approval in Developing Countries is not an Option' (Online First, requiring subscription, goddammit).

What struck me initially was the obviousness of the title: how is that news? It is like having an article called 'Eating people: some arguments against'. And in a certain way, the point of the article is obvious: when there is an appropriate body in developing countries to review human subjects research conducted by anyone (local or from abroad), then it should be reviewed. The authors cite a published article about research conducted in Nepal, which did not have local Nepalese research ethics committee approval. It doesn't sound like a very risky study, but that is not the point. Nepal has an ethics committee that could have reviewed it, and it was not even submitted.

What makes the article publication-worthy are the underlying issues. Central among them is who should have ensured that the study was submitted to local review. Ethics committees are not detective agencies, who scour the community to find out who is doing research on what. Researchers have to volunteer this information; they also have to know that there is a committee to submit their research to. In many developing countries, this is not straightforward: in some settings, research ethics committees may not exist; where they exist, they may only review certain kinds of (biomedical) studies; and even if they do exist and they could review a certain study, getting information about them and their procedures can be unreasonably taxing for scientists. Compounding the problems, some committees may be dysfunctional and intolerably slow, undermining motivations to bother looking for them.

Perhaps if a study is conducted by a developed world institution, their own research ethics committee should ensure that scientists make good faith efforts to get their research reviewed where it will be conducted, or help them get it reviewed. Or journals should not publish articles in which researchers failed to get their research reviewed where it really is human subjects research, and there really is an adequate body that can appropriately assess its ethics. The authors rightly point out that if researchers from Nepal were to do a research study in the UK or USA, but only sought ethics approval for it in Nepal, and published it, this would be considered scandalous -- but when developed world institutions do the same in the developing world, there is far less concern, even when committee members do not know much more about Nepal than Everest expeditions.

So it is not news that local ethics committee review in developing world ought to be reviewed; the news is how this requirement continues to fall through the gaps.

Labels: , , , ,

Saturday, April 16, 2011

The globalization of research ethics committees: paternalism, ethical imperialism or partnership

Research, the story goes, has become increasing global: there is more clinical and behavioral research involving human participants in more places in the world now than ever before in human history. These things don't just happen, so it is interesting to reflect on the meaning of the march of research to all points of the compass. Is it because there is an overwhelming humanitarian concern about those who are sick in the most impoverished areas of the world? Or is it because far-flung (at least, from North America and Europe) countries are a friendly business environment as health-related research becomes more and more about developing profitable interventions and devices?

As research projects and institutions are rapidly springing up around the world like mushrooms, the development of ethics committees to review such research globally is moving at a much more leisurely pace. In many places in Africa, for instance, there is no local body with the authority or expertise to conduct an adequate ethical review of a scientific protocol. In this month's issue of Tropical Medicine and International Health (subscribers only, alas) Ravinetto et. al. argue that there always ought to be a double ethics review of research conducted/sponsored by foreign institutions in developing countries. The requirement for 'local' review -- in addition to review in the sponsor's institution -- appears in some ethics guidelines, and it does happen a good percentage of the time. But why ought it to happen? According to Ravinetto et. al., it ought to happen in order to produce a more comprehensive and balanced review process, which in turn better fulfills the central mission of ethics committees, i.e. to protect research participants and benefit communities affected by the research. A collaborative double review can avoid ethical imperialism (imposition of ethical standards of the richer countries on the poorer ones) and paternalism (in the assumption that only ethics committees in richer countries can really review research adequately). The current problem with double review (according to Ravinetto et. al.) is not just the unpleasant fact that some ethics committees in developing countries may be operating at a low standard. The problem is that ethics committees involved in the review of research often do not correspond with one another at all, and the possible benefits of collaboration are missed.

The points are well taken, but the paper seems to underrepresent some of the ethical challenges of ethical review in a context of global inequality. It should be remembered, for example, that sponsoring countries hold the purse-strings, including the portion of the budget that is supposed to go to the local institutions for administrative support (including financial support for the local ethics committee). When there are conflicts between foreign and local ethics committees, which one is more likely to have the greatest say? The ethical playing field, parallel to the political and socio-economic playing fields, is very uneven. What might help, besides greater collaboration between ethics committees, is greater investment in local scientific institutions in order to prevent the vast majority of research being funded and conducted by developed world institutions.

Labels: , ,